Forget Beyond Meat — Adaptive Biotechnologies just spiked 95% in its public trading debut, marking t

Adaptive Biotechnologies went public on Thursday, jumping 95% above its offer price at the open. That marked the best post-IPO pop of the year for any company, on an offer-to-open basis. The Seattle biotech, which provides tests used to diagnose and treat diseases, began trading shortly after noon ET under the ticker symbol ADPT. Visit Markets Insider's homepage for more stories. Adaptive Biotechnologies went public on Thursday, jumping 95% above its IPO price at the open. It marked the...